Results 1 to 10 of about 89,340 (260)
Delaying Treatment of Ocular Hypertension [PDF]
Archives of Ophthalmology, 2010 To compare the safety and efficacy of earlier vs later treatment in preventing primary open-angle glaucoma (POAG) in individuals with ocular hypertension.One thousand six hundred thirty-six individuals with intraocular pressure (IOP) from 24 to 32 mm Hg in 1 eye and 21 to 32 mm Hg in the fellow eye were randomized to observation or to topical ocular ...
M. Roy Wilson +9 more
openaire +3 more sources
Ocular hypertension and posture. [PDF]
British Journal of Ophthalmology, 1983 Thirty-seven patients with ocular hypertension (OH) and 29 age matched controls were studied. Intraocular pressure (IOP) measurements were made in the sitting position and, immediately after changing posture, in the lying position. Sixty-three (85%) of the OH eyes and all the control eyes showed either stable IOP readings on changing posture of small ...
T J Leonard +3 more
openaire +3 more sources
Malignant Hypertension: Ocular Manifestations [PDF]
TheScientificWorldJOURNAL, 2006 Malignant hypertension may be the first manifestation of systemic hypertension. We report a clinical case of a Caucasian 41-year-old man with no previous history of blood hypertension seen at casualty because of blurred vision. Fundus examination disclosed optic disk swelling, retinal hemorrhages and infarcts. The blood pressure was 220/130 mmHg. After
Silvia Muñoz +2 more
openaire +3 more sources
Intraocular Pressure Fluctuation: Is It Important? [PDF]
, 2018 Elevated intraocular pressure (IOP) is a major risk factor for the development and progression of glaucoma. Previous prospective, randomized, long-term studies have demonstrated the strength of IOP reduction in slowing the progression of disease.
Caprioli, Joseph, Kim, Ji Hyun
core +5 more sources
Progression from ocular hypertension to visual field loss in the English hospital eye service [PDF]
, 2020 Background There are more than one million National Health Service visits in England and Wales each year for patients with glaucoma or ocular hypertension (OHT).
Azuara-Blanco, A. +5 more
core +2 more sources
The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review [PDF]
, 2017 The acute and chronic effects of repeated intravitreal antivascular endothelial growth factor (VEGF) injections on intraocular pressure have not been fully characterized, and the development of sustained ocular hypertension could adversely affect ...
Bracha, Peter +4 more
core +1 more source
Glycocalyx Degradation in Retinal and Choroidal Capillary Endothelium in Rats with Diabetes and Hypertension [PDF]
, 2010 Endothelial glycocalyx (GCX) has been reported as a protective factor for vascular endothelial cells (VEC) in diabetes and hypertension. However, the involvement of GCX impairment in ocular vasculopathy remains unclear.
Kumase, Fumiaki +5 more
core +1 more source
Ocular hypertension in myopia: analysis of contrast sensitivity [PDF]
, 2018 Purpose: we evaluated the evolution of contrast sensitivity reduction in patients affected by ocular hypertension and glaucoma, with low to moderate myopia.
Arrico, L +4 more
core +1 more source
, 2021 Ocular hypertension occurs when intraocular pressure (IOP) is greater than the normal range with no evidence of vision loss or damage to the optic nerve. Individuals with ocular hypertension have an increased risk for glaucoma. The mean normal IOP is 15 mmHg and the mean IOP of untreated glaucoma is 18 mmHg.
Kara Rickford, Daniel Laroche
openaire +4 more sources
Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs. [PDF]
, 2019 There is a limit beyond which increasing either the concentration of a prostaglandin analog (PGA) or its dosing frequency fails to produce increases in ocular hypotensive efficacy with topical dosing.
Alm +36 more
core +2 more sources